Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.54 |
| ▸ | LMNA | P02545 | 5/20 | 0.54 |
| ▸ | CCR1 | P32246 | 2/20 | 0.54 |
| ▸ | CCR5 | P51681 | 2/20 | 0.54 |
| ▸ | CCR8 | P51685 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | METAP1 | P53582 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.54 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.54 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 5/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | ALPL | P05186 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL650000 | 1.00 | KDM4E (0.54) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL30088399 | 1.00 | KDM4E (0.54) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL26499031 | 1.00 | KDM4E (0.54) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL24492797 | 0.98 | KDM4E (0.52) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL26499340 | 0.98 | KDM4E (0.52) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL27842924 | 0.98 | KDM4E (0.52) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL2188788 | 0.98 | KDM4E (0.52) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL14425486 | 0.98 | KDM4E (0.52) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL21334236 | 0.98 | KDM4E (0.52) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL26498677 | 0.98 | KDM4E (0.52) | KDM4ELMNACCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190345131-A1 | PD-1/PD-L1 INHIBITORS | GILEAD SCIENCES, INC. | 2019-11-14 | — | — | US | disclosed |
| WO-2019204609-A1 | PD-1/PD-L1 INHIBITORS | GILEAD SCIENCES, INC. (US) | 2019-10-24 | — | — | WO | disclosed |
| EP-2935293-B1 | IRIDIUM COMPLEXES AND THEIR USE IN ELECTRONIC DEVICES, ESPECIALLY ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-08-21 | — | — | EP | disclosed |
| US-9899612-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-02-20 | — | — | US | disclosed |
| US-9899612-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2018-02-20 | — | — | US | disclosed |
| US-20150318498-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2015-11-05 | — | — | US | disclosed |
| US-20150318498-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2015-11-05 | — | — | US | disclosed |
| US-20140284585-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2014-09-25 | — | — | US | disclosed |
| US-20140284585-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2014-09-25 | — | — | US | disclosed |
| US-8778508-B2 | Light-emitting organometallic complexes | UNIVERSAL DISPLAY CORPORATION (US) | 2014-07-15 | — | — | US | disclosed |
| US-8778508-B2 | Light-emitting organometallic complexes | UNIVERSAL DISPLAY CORPORATION (US) | 2014-07-15 | — | — | US | disclosed |
| US-8519130-B2 | Method for synthesis of iriduim (III) complexes with sterically demanding ligands | UNIVERSAL DISPLAY CORPORATION (US) | 2013-08-27 | — | — | US | disclosed |
| US-8519130-B2 | Method for synthesis of iriduim (III) complexes with sterically demanding ligands | UNIVERSAL DISPLAY CORPORATION (US) | 2013-08-27 | — | — | US | disclosed |
| WO-2009073246-A1 | METHOD FOR THE SYNTHESIS OF IRIDIUM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS | UNIVERSAL DISPLAY CORPORATION (US) | 2009-06-11 | — | — | WO | disclosed |
| WO-2009073245-A1 | LIGHT-EMITTING ORGANOMETALLIC COMPLEXES | UNIVERSAL DISPLAY CORPORATION (US) | 2009-06-11 | — | — | WO | disclosed |
| US-20090124805-A1 | METHOD FOR SYNTHESIS OF IRIDUIM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS | UNIVERSAL DISPLAY CORPORATION | 2009-05-14 | — | — | US | disclosed |
| US-20090124805-A1 | METHOD FOR SYNTHESIS OF IRIDUIM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS | UNIVERSAL DISPLAY CORPORATION | 2009-05-14 | — | — | US | disclosed |
| US-20090108737-A1 | LIGHT-EMITTING ORGANOMETALLIC COMPLEXES | UNIVERSAL DISPLAY CORPORATION | 2009-04-30 | — | — | US | disclosed |
| US-20090108737-A1 | LIGHT-EMITTING ORGANOMETALLIC COMPLEXES | UNIVERSAL DISPLAY CORPORATION | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090108737-A1 | LIGHT-EMITTING ORGANOMETALLIC COMPLEXES | CRY1, LAGE3, CRY2 | KDM4E 1922/4885LMNA 4024/4885CCR1 2905/4885 |
| US-20150318498-A1 | Metal Complexes | SOD1, AP1M1, AP3M1 | KDM4E 3816/4885LMNA 4436/4885CCR1 2964/4885 |
| US-20190345131-A1 | PD-1/PD-L1 INHIBITORS | PDCD1, CD274, PDCD1LG2 | KDM4E 746/4885LMNA 2279/4885CCR1 502/4885 |
| US-20090124805-A1 | METHOD FOR SYNTHESIS OF IRIDUIM (III) COMPLEXES WITH STERICALLY DEMANDING LIGANDS | PAICS, ITPA, MPI | KDM4E 4012/4885LMNA 4632/4885CCR1 985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.